Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transthyretin Amyloid Cardiomyopathy: Stabilization Assessed by Cardiac Magnetic Resonance

NCT04513600 is registered in ClinicalTrials.gov with The Christ Hospital as lead sponsor.

NCT NCT04513600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transthyretin Amyloid Cardiomyopathy: Stabilization Assessed by Cardiac Magnetic Resonance
Lead sponsor
The Christ Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 1, 2023
Enrollment
131 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloidosis